IL17A and myeloid sarcoma: We found that all MS subgroups showed increased percentages of effector T cells, memory and antigen-presenting B cells, and CD4+ and CD8+ T cells producing TNF-α, IL-17, and IFN-γ, as well as CD19+ B cells secreting TNF-α compared with HC.